Crystalline anhydrate with anticholinergic efficacy

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S291000

Reexamination Certificate

active

07968717

ABSTRACT:
The invention relates to a new crystalline anhydrate of tiotropium bromide, processes for preparing it and its use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.

REFERENCES:
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 6608055 (2003-08-01), Sieger et al.
patent: RE39820 (2007-09-01), Banholzer et al.
patent: 2004/0087793 (2004-05-01), Banholzer et al.
patent: 0418716 (1990-09-01), None
patent: WO 02/30928 (2002-04-01), None
Byrn, S.R. et. al. Chapter 3 “The X-Ray Powder Diffraction Method” in Solid State Chemistry of Drugs 2nd Edition, SSCI, 1999, pp. 59-67.
Littner, M. R. et. al. “Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease” American Journal of Respiratory and Critical Care Medicine 2000, 161, 1136-1142.
“Guidelines for Authors” Journal of Organic Chemistry 2007, 72, 13A-27A.
Zell et. al. “Investigation of Polymorphism in Aspartame and Neotame Using Solid-State NMR Spectroscopy.” Tetrahedron 2000, 56, 6603-6616.
Stahl, P.H., et al. “Handbook of Pharmaceutical Salts Properties, Selection and Use”, 2002, Wiley-VCH, Weinheim-New York, p. 98, XP002268934.
B.Disse, et al. “Tiotopium (SpirivaTM): Mechanistical Considerations and Clinical Profile in Obstructive Lung Disease” Life Sciences, vol. 64, Nos. 6/7, p. 457-464, 1999.
Docoslis et al.; Characterization of the Distribution, Polymorphism, and Stability of Nimodipine in Its Solid Dispersions in Polyethylene Glycol by Micro-Raman Spectroscopy and Powder X-Ray Diffraction; The AAPS Journal 2007; vol. 9; No. 3; Article 43; pp. E361-E370.
Brittain; Physical Characterization of Pharmaceutical Solids; Drugs and the Pharmaceutical Sciences; vol. 70; pp. 2-35, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Crystalline anhydrate with anticholinergic efficacy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline anhydrate with anticholinergic efficacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anhydrate with anticholinergic efficacy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2711150

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.